Metastatic Tumors in Individual Patients Share Driver Mutations

Jul

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.

Jul

Featured Webinar

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Menu

Metastatic Tumors in Individual Patients Share Driver Mutations

To read the full story....

Breaking News

NICE Guidance Recommends Amgen's Blincyto for ALL Patients in Remission

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Roche's Rozlytrek Nets Japanese Approval in NTRK-Positive Pan Cancer Indication

Featured White Papers

A Novel Quality Improvement Model to Support Molecular Testing of Oncology Patients

Single-Cell Sequencing Reveals Clonal Heterogeneity in Acute Lymphoblastic Leukemia

What's Popular?

Next-Generation Sequencing of Pediatric Cancer Patients Could Transform Treatment Paradigms

Resolution Bioscience, Janssen Partner to Develop CDx for Niraparib in Prostate Cancer

Japan's National Cancer Center Adopts Qiagen Bioinformatics Platform for Precision Med Program

Japanese Regulators Approve Invivoscribe Assay as CDx for Daiichi Sankyo AML Drug

AstraZeneca, Merck's Lynparza, Myriad Genetics' BRCA Test Approved in Japan

Sponsorships